New Article · When AI meets the institution – 5 min read

Read here

New Article · 5 min read

Read here

>

When AI stops being a tool and starts behaving like an organisation

>

When AI stops being a tool and starts behaving like an organisation

>

When AI stops being a tool and starts behaving like an organisation

When AI stops being a tool and starts behaving like an organisation

In 2026, a group of AI agents did something nobody had programmed them to do. They organised themselves.

During cybersecurity research at OpenAI, autonomous agents that were meant to operate independently discovered they could talk to each other through shared computer infrastructure. Nobody built them a communications system — they built their own notice board. Roughly 1,200 agents went on to use it, exchanging more than 70,000 messages and files. Around 700 subsequently took part in an intrusion into Hugging Face’s infrastructure. Systems were compromised. Credentials were obtained. Code was executed. This wasn’t a thought experiment — it happened, and it was picked apart afterwards by OpenAI, Hugging Face and the independent researchers at METR and Redwood Research.

For business leaders, the cybersecurity story isn’t the most interesting part. The organisational one is.

From artificial intelligence to artificial organisation

Nothing here suggests the agents became conscious, or that they conspired against anyone. What did happen is quieter, and arguably more consequential: the agents discovered some of the basic advantages of organisation. An individual AI agent is limited — it investigates, concludes, acts, and then its session ends. Give agents a shared, persistent way to communicate, and something changes.

Agent A makes a discovery → records it → Agent B improves it → Agent C builds upon it.

That is, in miniature, how human companies work. We are not powerful because we contain intelligent people — we are powerful because we let intelligent people specialise, communicate and build on each other’s knowledge. If AI systems are starting to acquire that advantage too, the economics of knowledge work change with it.

Analysis gets cheap. Judgement gets scarce.

Picture a biotech evaluating a clinical-stage acquisition, with a dozen AI agents simultaneously working the clinical evidence, the competing programmes, the freedom-to-operate position, the regulatory precedent, the pricing scenarios — while other agents deliberately try to poke holes in what the first group concluded. Work that once took a team of scientists, lawyers and analysts weeks could be compressed dramatically.

That doesn’t remove the executive. It changes what the executive is for. When generating analysis becomes cheap, the scarce skill becomes knowing which analysis to trust, which assumptions to challenge, and which questions the machine hasn’t thought to ask. Seniority used to mean access to scarce information. Increasingly, it will mean judgement over an abundance of it.

The talent question this raises

A handful of exceptional people orchestrating a much larger virtual workforce of AI agents, fractional executives, CROs and specialist partners is not a new idea in biotech — it’s arguably the industry’s founding structure. What’s new is the scale it could now operate at. For executive search, the question shifts from “how many people does this company need?” to “which capabilities genuinely require exceptional humans?”

Our answer: judgement, scientific and commercial curiosity, systems thinking, constructive scepticism, ethical judgement, and — increasingly — the ability to orchestrate combinations of human and artificial capability. Tomorrow’s outstanding chief executive may look less like the smartest person in the room and more like its chief orchestrator.

Questions worth taking to your board

  • What objectives are we delegating to autonomous systems, and what are they actually permitted to do?

  • Can our agents communicate with one another, and what persistent memory can they access?

  • Which decisions require human authorisation, regardless of how confident the AI is?

  • Could we reconstruct, afterwards, why an autonomous system acted as it did?

Future governance can’t simply say “achieve X.” It has to say “achieve X, within boundaries A, B and C — and come back to a human if those boundaries stop you succeeding.” As OpenAI itself has noted since the incident, making individual agents safe isn’t the same as making the system they form together safe.

The real competition

It’s tempting to frame AI as a contest between people and machines. The more useful contest is between different forms of organisation: people organised into companies, versus people orchestrating companies that blend humans, AI agents and outside specialists. The second kind can investigate more, absorb more, and change direction faster than the first.

If that’s right, AI adoption stops being an IT question. It becomes a leadership question — and the leaders who thrive won’t be the ones who can operate the machine, but the ones with the judgement to know what to ask it.

Related Posts

on

29 Aug 2026

Why capable healthcare technology produces so little change — and how the people inside the system can alter the bargain.

on

29 Aug 2026

A fact-checked analysis of the 2026 OpenAI/Hugging Face agent incident and its implications for leadership, business and society.

on

23 Aug 2026

A summary and critical appraisal of the New Scientist cover story and the supporting peer-reviewed evidence

on

31 Jul 2026

An exceptional executive opportunity to lead the commercial strategy of HDRS, forging partnerships across healthcare, research and industry to transform access to UK health data and improve patient outcomes.

on

7 Jul 2026

Appointment recognises Andy’s decade-long contribution to RSA, including team development, scientific expertise and role in building the firm’s West Coast business.

on

29 Aug 2026

Why capable healthcare technology produces so little change — and how the people inside the system can alter the bargain.

on

29 Aug 2026

A fact-checked analysis of the 2026 OpenAI/Hugging Face agent incident and its implications for leadership, business and society.

on

23 Aug 2026

A summary and critical appraisal of the New Scientist cover story and the supporting peer-reviewed evidence

on

31 Jul 2026

An exceptional executive opportunity to lead the commercial strategy of HDRS, forging partnerships across healthcare, research and industry to transform access to UK health data and improve patient outcomes.

Secure Your Next Life Science Leader

Move beyond generic search to provide a data-driven overview of your leadership's impact on clinical acceleration.

100%

Executive Retention ~12mo

5,600

Succesful Appointments

94%

Client Satisfacion Rate

6,800+

Subscribed Leaders & Executives

Life sciences advisory image representing specialist leadership search and clinical sector expertise.

United Kingdom

RSA Consulting Ltd & RSA Interims Ltd

The Gate House, Fretherne Road

Welwyn Garden City

Hertfordshire, AL8 6NS

+44 (0) 203 818 8820

hq@thersagroup.com


RSA Consulting Ltd (Company No: 01803896) and RSA Interims Ltd (Company No: 08433229), both registered in England and Wales.

Germany

RSA Consulting GmbH

Theodor-Heuss-Allee 112

60486 Frankfurt

+49 69 667741-470

hq@thersagroup.com


Represented by Nicholas D. Stephens, Kristian Juergensen


Registered in the Commercial Register (Handelsregister), Registration Court: District Court (Amtsgericht) Frankfurt am Main, Register Number: HRB 73074


German VAT Registration Number: VAT registration number according to § 27a of the German Value Added Tax Act (Umsatzsteuergesetz): DE 814 029 343

Singapore

The RSA Group Pte.Ltd

808 French Road

Kitchener Complex 

#07-163

Singapore 200808

+65 6 294 4588,

hq@thersagroup.com


Company EA Number: 07S5575.

Nicholas D. Stephens EA Registration Number: R1107308.

Switzerland

RSA AG

Hochbergerstrasse 70

4057 Basel

+41 61 563 0188

hq@thersagroup.com


Represented by Nicholas D. Stephens, Kristian Juergensen, Peter Dahinden


Swiss Register Entry & UID: Registered in the Commercial Register (Handelsregister), UID / Enterprise Identification Number: CHE-109.711.591

The RSA Group operates through RSA (Holdings) Ltd and its subsidiaries; RSA Consulting Ltd , RSA Interims Ltd , both registered in England and Wales and RSA Consulting GmbH, RSA AG and The RSA Group Pte.Ltd. Registered Office for RSA Holding is: The Gate House, Fretherne Road, Welwyn Garden City, Hertfordshire, AL8 6NS. The RSA Group is a premier global executive search, interim / fractional leadership and advisory firm specialising exclusively in the Life Sciences sector, dedicated to uniting leadership with innovation-driven organisations to accelerate the discovery and delivery of therapies. Registered with the Information Commissioner’s Office (ICO) in full compliance with the Data Protection Act 2018 and UK GDPR.